• Study on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    France Greece Poland Spain

  • Study on Switching to Insulin Glargine 300 U/ml from Insulin Glargine 100 U/ml for Patients with Type 2 Diabetes and Kidney Problems

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain

  • Study of Ipilimumab and Nivolumab for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of Ruxolitinib with Brentuximab or Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study Comparing CT-P55 and Secukinumab for Moderate to Severe Plaque Psoriasis Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study on the Effectiveness of Allo-APZ2-CVU for Patients with Long-Term, Non-Healing Venous Leg Ulcers

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Czechia France Germany Hungary Italy +4

  • Study on ITPP and Sodium Chloride for Patients with COVID-19 and Other Lung Infections Facing Breathing Problems

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study of Cenobamate for Children with Partial-Onset Seizures

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Spain

  • Title: Safety and effectiveness study of pegzilarginase weekly injections in children under 2 years old with Arginase 1 Deficiency

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Portugal

  • Long-Term Study on Oxytocin for Children with Prader-Willi Syndrome Up to Age 4

    Not recruiting

    2 1 1
    Investigated Drugs:
    France

powered by